You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Nuclear Medicine & Radio Pharmaceuticals Market By Key Players (Siemens Healthcare, Philips Healthcare, Toshiba, Shimadzu)

The report on the Global Nuclear Medicine & Radio Pharmaceuticals Market has published by Lexis Business Insights. The report provides the client the latest trending insights about the Nuclear Medicine & Radio Pharmaceuticals market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Nuclear Medicine & Radio Pharmaceuticals market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.
Some of the key industry players that are operating in the Nuclear Medicine & Radio Pharmaceuticals market are:
Toshiba
Siemens Healthcare
Biosensors International Group Ltd.
Shimadzu
TriFoil Imaging
Esaote
Hitachi
GE Healthcare
Philips Healthcare
Carestream
Through the month of the analysis, research analysts predicted that the Nuclear Medicine & Radio Pharmaceuticals market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Nuclear Medicine & Radio Pharmaceuticals market, increasing the market growth.
Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.
The questions that are answered in the report:
What are the challenges for the Nuclear Medicine & Radio Pharmaceuticals market created by the outbreak of the global pandemic?
What are the drivers that are shaping the Nuclear Medicine & Radio Pharmaceuticals market?
What are the top opportunities that are currently ruling the market?
What are the segments of the Nuclear Medicine & Radio Pharmaceuticals market that are given in the report?
What are the developing regions in the Nuclear Medicine & Radio Pharmaceuticals market?
Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.
Market Segmentation
The Nuclear Medicine & Radio Pharmaceuticals market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.
The Nuclear Medicine & Radio Pharmaceuticals market is segmented into Product Types:
Diagnostic Medicine: SPECT Radiopharmaceuticals
PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters
Alpha Emitters
Brachytherapy Isotopes.
The Nuclear Medicine & Radio Pharmaceuticals market is segmented into By End User/Application:
Diagnostic Applications: SPECT
PET.
Therapeutic Applications: Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Other Therapeutic Applications.
The major points that are covered in the report:
Overview: In this section, the global Nuclear Medicine & Radio Pharmaceuticals Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.
Strategies Analysis of Industry Players: This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.
Essential Market Trends: Depth analysis of the market’s latest and future trends is provided in this section.
Market Forecasts: In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Nuclear Medicine & Radio Pharmaceuticals Market.
Regional Analysis: In the global Nuclear Medicine & Radio Pharmaceuticals market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.
Segment Analysis: Accurate and reliable foretell about the market share of the essential sections of the Nuclear Medicine & Radio Pharmaceuticals market is provided.
Regional Segmentation
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Type (2020-2026)
1.5.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
1.5.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
1.6 Market by Application
1.6.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2020-2026)
1.6.2 Diagnostic Applications: SPECT, PET.
1.6.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.7 Nuclear Medicine & Radio Pharmaceuticals Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine & Radio Pharmaceuticals Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Nuclear Medicine & Radio Pharmaceuticals Market
3.1 Value Chain Status
3.2 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
3.2.3 Labor Cost of Nuclear Medicine & Radio Pharmaceuticals
3.2.3.1 Labor Cost of Nuclear Medicine & Radio Pharmaceuticals Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Toshiba
4.1.1 Toshiba Basic Information
4.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.1.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.1.4 Toshiba Business Overview
4.2 Siemens Healthcare
4.2.1 Siemens Healthcare Basic Information
4.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.2.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.2.4 Siemens Healthcare Business Overview
4.3 Biosensors International Group, Ltd.
4.3.1 Biosensors International Group, Ltd. Basic Information
4.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.3.3 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.3.4 Biosensors International Group, Ltd. Business Overview
4.4 Shimadzu
4.4.1 Shimadzu Basic Information
4.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.4.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.4.4 Shimadzu Business Overview
4.5 TriFoil Imaging
4.5.1 TriFoil Imaging Basic Information
4.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.5.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.5.4 TriFoil Imaging Business Overview
4.6 Esaote
4.6.1 Esaote Basic Information
4.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.6.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.6.4 Esaote Business Overview
4.7 Hitachi
4.7.1 Hitachi Basic Information
4.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.7.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.7.4 Hitachi Business Overview
4.8 GE Healthcare
4.8.1 GE Healthcare Basic Information
4.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.8.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.8.4 GE Healthcare Business Overview
4.9 Philips Healthcare
4.9.1 Philips Healthcare Basic Information
4.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.9.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.9.4 Philips Healthcare Business Overview
4.10 Carestream
4.10.1 Carestream Basic Information
4.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Profiles, Application and Specification
4.10.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Market Performance (2015-2020)
4.10.4 Carestream Business Overview

5 Global Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Regions
5.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Regions
5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions (2015-2020)
5.2 North America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
5.6 South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

6 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Countries
6.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
6.1.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
6.1.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
6.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.2.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
6.3 Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

7 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Countries
7.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
7.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
7.1.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.2 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.2.1 Germany Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.3 UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.3.1 UK Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.4 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.4.1 France Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.5 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.5.1 Italy Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.6 Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.6.1 Spain Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
7.7 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.7.1 Russia Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19

8 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Countries
8.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
8.2 China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.2.1 China Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
8.3 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.3.1 Japan Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
8.4 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.4.1 South Korea Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
8.5 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.6 India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.6.1 India Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
8.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19

9 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Countries
9.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
9.2 Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.3 UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.5 Nigeria Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.6 South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

10 South America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Countries
10.1 South America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
10.1.1 South America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
10.1.2 South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
10.1.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
10.2 Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.2.1 Brazil Nuclear Medicine & Radio Pharmaceuticals Market Under COVID-19
10.3 Argentina Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.4 Columbia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Chile Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

11 Global Nuclear Medicine & Radio Pharmaceuticals Market Segment by Types
11.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Types (2015-2020)
11.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Types (2015-2020)
11.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Sales and Price (2015-2020)
11.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Sales and Price (2015-2020)

12 Global Nuclear Medicine & Radio Pharmaceuticals Market Segment by Applications
12.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Applications (2015-2020)
12.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Applications (2015-2020)
12.2 Diagnostic Applications: SPECT, PET. Sales, Revenue and Growth Rate (2015-2020)
12.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Sales, Revenue and Growth Rate (2015-2020)

13 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Regions (2020-2026)
13.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate (2020-2026)
13.2 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Regions (2020-2026)
13.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2020-2026)
13.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2020-2026)
13.2.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2020-2026)
13.2.4 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2020-2026)
13.2.5 South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2020-2026)
13.3 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Types (2020-2026)
13.4 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Applications (2020-2026)
13.5 Nuclear Medicine & Radio Pharmaceuticals Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140